Paragonix Technologies

Getinge has agreed to acquire 100% of Paragonix Technologies, a leader in organ transport and preservation, for an estimated $477 million. The acquisition marks Getinge's entry into the organ preservation and transportation market.

Paragonix Technologies entered into a supply agreement with Sanbor Medical for the manufacture and assembly of SherpaPak Cardiac and Kidney Transport Systems.

Paragonix Technologies entered into an exclusive distribution agreement with Pacific West Medical Sales to market its SherpaPak Cardiac and Kidney Transport Systems in greater Southern California.